Back
Black Diamond Therapeutics Stock Price Chart
Sponsored
BDTX
Sponsored
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Sell
27
BDTX
Black Diamond Therapeutics
Last Price:
2.87
Seasonality Move:
21.63%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDTX is experiencing selling pressure, which indicates risk of future bearish movement.
Black Diamond Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.2 | Sell |
20-day SMA: | 3.09 | Sell |
50-day SMA: | 3.94 | Sell |
200-day SMA: | 4.9 | Sell |
8-day EMA: | 3.11 | Sell |
20-day EMA: | 3.22 | Sell |
50-day EMA: | 3.79 | Sell |
200-day EMA: | 4.4 | Sell |
Black Diamond Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.2 | Sell |
Relative Strength Index (14 RSI): | 35.95 | Sell |
Chaikin Money Flow: | -398563 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.94 - 3.36) | Sell |
Bollinger Bands (100): | (3.56 - 5.88) | Sell |
Black Diamond Therapeutics Technical Analysis
Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Black Diamond Therapeutics Stock
Is Black Diamond Therapeutics Stock a Buy?
- Black Diamond Therapeutics share price is 2.85 while BDTX 8-day simple moving average is 3.20, which is a Sell signal.
- The stock price of BDTX is 2.85 while Black Diamond Therapeutics 20-day SMA is 3.09, which makes it a Sell.
- Black Diamond Therapeutics 50-day simple moving average is 3.94 while BDTX share price is 2.85, making it a Sell technically.
- BDTX stock price is 2.85 and Black Diamond Therapeutics 200-day simple moving average is 4.90, creating a Sell signal.
BDTX Technical Analysis vs Fundamental Analysis
Sell
27
Black Diamond Therapeutics (BDTX)
is a Sell
Is Black Diamond Therapeutics a Buy or a Sell?
-
Black Diamond Therapeutics stock is rated a Sell
The current Black Diamond Therapeutics [BDTX] share price is $2.85. The Score for BDTX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
Black Diamond Therapeutics Stock Info
Market Cap:
161.27M
Price in USD:
2.85
Share Volume:
444.55K
Black Diamond Therapeutics 52-Week Range
52-Week High:
7.66
52-Week Low:
2.09
Sell
27
Black Diamond Therapeutics (BDTX)
is a Sell
Black Diamond Therapeutics Share Price Forecast
-
What is the Black Diamond Therapeutics stock price today?
The Black Diamond Therapeutics stock price is 2.85 USD today. -
Will BDTX stock go up or go down?
Black Diamond Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Black Diamond Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Black Diamond Therapeutics is overvalued.
Is Black Diamond Therapeutics Stock a Buy?
- Black Diamond Therapeutics share price is 2.85 while BDTX 8-day exponential moving average is 3.11, which is a Sell signal.
- The stock price of BDTX is 2.85 while Black Diamond Therapeutics 20-day EMA is 3.22, which makes it a Sell.
- Black Diamond Therapeutics 50-day exponential moving average is 3.79 while BDTX share price is 2.85, making it a Sell technically.
- BDTX stock price is 2.85 and Black Diamond Therapeutics 200-day simple moving average is 4.40, creating a Sell signal.
Fundamental Analysis of Black Diamond Therapeutics
Is Black Diamond Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and an increase next year of $0.02 per share.
Technical Analysis of Black Diamond Therapeutics
Should I short Black Diamond Therapeutics stock?
- BDTX Moving Average Covergence Divergence (MACD) indicator is -0.2, suggesting Black Diamond Therapeutics is a Sell
- Black Diamond Therapeutics Relative Strength Index (RSI) is 35.95, which suggest Black Diamond Therapeutics is oversold
- The Bollinger Bands (25) for Black Diamond Therapeutics is (2.94 - 3.36), which suggest Black Diamond Therapeutics is a Sell
- The Bollinger Bands (100) for Black Diamond Therapeutics is (3.56 - 5.88), which suggest Black Diamond Therapeutics is a Sell
* Black Diamond Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.